Dr. Carrasco Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dr. Carrasco Pain Relief
Generic name: MENTHOL
Manufacturer: Carrasco Enterprises, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: befa8526-f468-428e-a829-422c2ea48612
SPL ID: 4ff6ae0f-1090-c66a-e063-6294a90a26a0
Version: 6
Effective date: 2026-04-21
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:20:14

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Dr. Carrasco Pain Relief	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Carrasco Enterprises, Inc.	openfda.manufacturer_name
ndc	package	69921-024-01	openfda.package_ndc
ndc	product	69921-024	openfda.product_ndc
ndc11	package	69921002401	derived:openfda.package_ndc
rxcui		1148430	openfda.rxcui
spl id		4ff6ae0f-1090-c66a-e063-6294a90a26a0	id
spl set id		befa8526-f468-428e-a829-422c2ea48612	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: For external use only. Not intended for ingestion. Do not use: On damaged or broken skin. When using this product Avoid contact with the eyes. • Do not bandage tightly. Stop use and ask a doctor if: Rash or irritation develops and lasts. • condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.